The Impact of the SARS-CoV-2 Pandemic on Human Immunodeficiency Virus and Bacterial Sexually Transmitted Infection Testing and Diagnosis in Oregon
Timothy W. Menza, Amy Zlot, Jillian Garai, Sarah Humphrey, Josh Ferrer
Abstract
ABSTRACT: Human immunodeficiency virus, Neisseria gonorrhoeae/Chlamydia trachomatis, and syphilis testing decreased with the implementation of mitigation measures for SARS-CoV-2 and did not return to 2019 levels by September 2020. However, primary and secondary syphilis diagnoses increased during mitigation measures. Sexual health services are essential during the SARS-CoV-2 pandemic.
Topics & Concepts
MedicineSyphilisChlamydia trachomatisPandemicNeisseria gonorrhoeaeChlamydiaVirologySexually transmitted diseaseHuman immunodeficiency virus (HIV)ImmunologyGonorrheaTreponematosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Internal medicineMicrobiologyInfectious disease (medical specialty)BiologyDiseaseHIV, Drug Use, Sexual RiskReproductive tract infections researchHIV/AIDS Research and Interventions